Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Pneumonia
Sort By
Newest First
Sign in
1 / 1
1 / 1
Vaccine
Pfizer Announces Positive Preliminary Results from a 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate for Disease Prevention in Infants
Pfizer
PR-M09-19-NI-028
Sep 11, 2019
FDA Approval
FDA Approves New Antibiotic to Treat Community-Acquired Bacterial Pneumonia
U.S. Food & Drug Administration
PR-M08-19-NI-061
Aug 21, 2019
Clinical Trials
Novel Pneumonia-Fighter Enters Pivotal Trial
Guy Tiene
Nice Insight
PAO-M08-17-NI-011
Aug 08, 2017
